Mark A. Goldberg
Director · INTENSITY THERAPEUTICS, INC.
Individual
- 2025
- Jul 20, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Mark A. Goldberg's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Roger Adsett - $47.51M in INSM purchases and sales in the last 12 months
- Xiaodong Wang - $46.84M in ONC purchases and sales in the last 12 months
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
- Matthew Gline - $46.17M in ROIV purchases and sales in the last 12 months
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark A. Goldberg?
Mark A. Goldberg is a corporate insider, tracked as Director of INTENSITY THERAPEUTICS, INC. (INTS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Mark A. Goldberg last file a Form 4?
The most recent primary Form 4 on record is dated 20 July 2026, one of 2 filings going back to 2025.